|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
The Schedule Contains Summary Financial Information Extracted From
Balance Sheets and Statements of Income
</LEGEND>
<CIK> 0000878616
<NAME> Human Pheromone Sciences, Inc.
<MULTIPLIER> 1
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 953,000
<SECURITIES> 0
<RECEIVABLES> 1,022,000
<ALLOWANCES> (54,000)
<INVENTORY> 368,000
<CURRENT-ASSETS> 2,340,000
<PP&E> 708,000
<DEPRECIATION> (689,000)
<TOTAL-ASSETS> 2,359,000
<CURRENT-LIABILITIES> 350,000
<BONDS> 0
0
3,706,000
<COMMON> 17,667,000
<OTHER-SE> (19,364,000)
<TOTAL-LIABILITY-AND-EQUITY> 2,359,000
<SALES> 1,755,000
<TOTAL-REVENUES> 2,785,000
<CGS> 856,000
<TOTAL-COSTS> 856,000
<OTHER-EXPENSES> 2,349,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 16,000
<INCOME-PRETAX> (440,000)
<INCOME-TAX> 0
<INCOME-CONTINUING> (440,000)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (440,000)
<EPS-BASIC> (0.13)
<EPS-DILUTED> (0.13)
</TABLE>
|
|